2,4-bis (p-hydroxyphenyl)-2-butenal (HPB242) induces apoptosis via modulating E7 expression and inhibition of PI3K/Akt pathway in SiHa human cervical cancer cells

Nutrition and Cancer

Volumn 64, Issue 8, 2012, Pages 1236-1244

  Kim, Man Sub ^a   Kim, Jung Hee ^a   Bak, Yesol ^a   Park, Yun Sun ^a   Lee, Dong Hun ^a   Kang, Jeong Woo ^a   Shim, Jung Hyun ^a,b   Jeong, Heon Sang ^c   Hong, Jin Tae ^c   Yoon, Do Young ^a  

^a Konkuk University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CYCLINE; FAS ANTIGEN; HPB 242; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN E7; PROTEIN P53; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN CONDENSATION; DRUG CYTOTOXICITY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; PHASE CONTRAST MICROSCOPY; PHOSPHORYLATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ALDEHYDES; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; HUMANS; I-KAPPA B PROTEINS; MAILLARD REACTION; NF-KAPPA B; PAPILLOMAVIRUS E7 PROTEINS; PHENOLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 84873659921     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.718405     Document Type: Article

References (43)

1. Chen L, Liu Q, Qin R, Le H, Xia R, et al.: Amplification and functional characterization of MUC1 promoter and gene-virotherapy via a targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in vitro. Int J Mol Med 15, 617-626, 2005.
2. Ji J and Zheng PS: Activation of mTOR signaling pathway contributes to survival of cervical cancer cells. Gynecol Oncol 117, 103-108, 2010.
3. Hung CF, Monie A, Alvarez RD, and Wu TC: DNA vaccines for cervical cancer: from bench to bedside. Exp Mol Med 39, 679-689, 2007.
4. Bae JH, Cheung JL, Lee SJ, Luk AC, Tong SY, et al.: Distribution of human papillomavirus type 58 variants in progression of cervical dysplasia in Korean women. J Microbiol Biotechnol 19, 1051-1054, 2009.
5. Sima N, Wang S, Wang W, Kong D, Xu Q, et al.: Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Gynecol Oncol 106, 299-304, 2007.
6. Bernard B, Pretet JL, Charlot JF, and Mougin C: Human papillomaviruses type 16 +and 18+ cervical carcinoma cells are sensitive to staurosporine- mediated apoptosis. Biol Cell 95, 17-26, 2003.
7. Mantovan, F and Banks L: Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines. Oncogene 18, 3309-3315, 1999.
8. Sima N, Wang W, Kong D, Deng D, Xu Q, et al.: RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Apoptosis 13, 273-281, 2008.
9. Liu Z-M: Calcium-mediated activation of PI3K and p53 leads to apoptosis in thyroid carcinoma cells. Cell Mol Life Sciences 64, 1428-1436, 2007.
10. Hu HZ, Yang YB, Xu XD, Shen HW, Shu YM, et al.: Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line. Acta Pharmacol Sin 28, 1819-1826, 2007.
11. Sabbatini P and McCormick F: Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent Apoptosis. J Biol Chem 274, 24263-24269, 1999.
12. Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S, et al.: The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. J Am Soc Nephrol 14, 1427-1434, 2003.
13. Jiang BH and Liu LZ: PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102, 19-65, 2009.
14. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, et al.: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85, 1999.
15. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, Jr., et al.: Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20, 1626-1638, 2000.
16. Rahman KW, Li Y, and Sarkar, FH: Inactivation of Akt and NF-kB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 48, 84-94, 2004.
17. Jing H and Kitts DD: Antioxidant activity of sugar-lysine Maillard reaction products in cell free and cell culture systems. Arch Biochem Biophys 429, 154-163, 2004.
18. Wijewickreme AN, Krejpcio Z, and Kitts DD: Hydroxyl scavenging activity of glucose, fructose, and ribose-lysine model maillard products. J Food Science 64, 457-461, 1999.
19. Yen WJ, Wang BS, Chang LW, and Duh PD: Antioxidant properties of roasted coffee residues. J Agric Food Chem 53, 2658-2663, 2005.
20. Yilmaz Y TR: Antioxidant activity of water-soluble Maillard reaction products. Food Chem 93, 273-278, 2005.
21. Lertittikula W, Benjakula S, and Tanakab M: Characteristics and antioxidative activity of Maillard reaction products from a porcine plasma protein-glucose model system as influenced by pH. Food Chem 100, 669-677, 2007.
22. Maillard M-N, Billaudb C, Chow Y-N, Ordonauda C, and Nicolas, J: Free radical scavenging, inhibition of polyphenoloxidase activity and copper chelating properties of model Maillard systems. LWT: Food Sci Technol 40, 1434-1444, 2007.
23. Manzocco L, Calligaris S, Mastrocola D, Nicoli MC, and Lerici CR: Review of non-enzymatic browning and antioxidant capacity in processed foods. Trends in Food Sci Technol 11, 340-346, 2000.
24. Rufían-Henares JA and Morales FJ: Functional properties of melanoidins: In vitro antioxidant, antimicrobial and antihypertensive activities. Food Res Int 40, 995-1002, 2007.
25. Yen G-C and Tsai L-C: Antimutagenicity of a partially fractionated Maillard reaction product. Food Chem 47, 11-15, 1993.
26. Lee YJ, Choi DY, Choi IS, Han JY, Jeong HS, et al.: Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2- butenal on amyloid-beta generation and inflammatory reactions via inhibition of NF-kappaB and STAT3 activation in cultured astrocytes and microglial BV-2 cells. J Neuroinflammation 8, 132, 2011.
27. Hwang I, Kim H, Woo K, Hong J, Hwang B, et al.: Isolation and characterisation of an a-glucosidase inhibitory substance from fructose-tyrosine Maillard reaction products. Food Chem 127, 122-126, 2011.
28. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, and Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119, 361-366, 1985.
29. Morozov A, Shiyanov P, Barr E, Leiden JM, and Raychaudhuri P: Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21. J Virol 71, 3451-3457, 1997.
30. Sherman L and Alloul N: Human papillomavirus type 16 expresses a variety of alternatively splicedmRNAs putatively encoding the E2 protein. Virology 191, 953-959, 1992.
31. Chen W, Li Z, Bai L, and Lin Y: NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci 16, 1172-1185, 2011.
32. Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, et al.: Role of NFkappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22, 3243-3251, 2003.
33. Marko D, Habermeyer M, Kemeny M, Weyand U, Niederberger E, et al.: Maillard reaction products modulating the growth of human tumor cells in vitro. Chem Res Toxicol 16, 48-55, 2003.
34. Obrenovich, M E and Monnier, V M: Apoptotic killing of fibroblasts by matrix-bound advanced glycation end products. Sci Aging Knowledge Environ pe3, 2005.
35. Sherr CJ: Cancer cell cycles. Science 274, 1672-1677, 1996.
36. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, et al.: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-7898, 2001.
37. Munger K, Phelps WC, Bubb V, Howley PM, and Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63, 4417-4421, 1989.
38. Spierings D, McStay G, Saleh M, Bender C, Chipuk J, et al.: Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 310, 66-67, 2005.
39. Sartorius U, Schmitz I, and Krammer PH: Molecular mechanisms of deathreceptor-mediated apoptosis. Chembiochem 2, 20-29, 2001.
40. Javvadi P, Segan AT, Tuttle SW, and Koumenis C: The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73, 1491-1501, 2008.
41. Carnero A: The PKB/AKT pathway in cancer. Curr Pharm Design 16, 34-44, 2010.
42. Hernandez-Flores G, Ortiz-Lazareno PC, Lerma-Diaz JM, Dominguez-Rodriguez JR, Jave-Suarez LF, et al.: Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence. BMC Cancer 11, 483, 2011.
43. Kwon HK, Hwang JS, So JS, Lee CG, Sahoo A, et al.: Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer 10, 392, 2010.